- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.82 Å
- Oligo State
- monomer
- Ligands
- 1 x 8BM: 4-(4-{[2-{[(3S)-1-acetylpyrrolidin-3-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl]amino}phenyl)-1-methylpiperazin-1-ium(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Planken, S. et al., Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR. J. Med. Chem. (2017)
- Release Date
- 2017-03-22
- Peptides
- Epidermal growth factor receptor: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A